JP2006528655A5 - - Google Patents

Download PDF

Info

Publication number
JP2006528655A5
JP2006528655A5 JP2006521652A JP2006521652A JP2006528655A5 JP 2006528655 A5 JP2006528655 A5 JP 2006528655A5 JP 2006521652 A JP2006521652 A JP 2006521652A JP 2006521652 A JP2006521652 A JP 2006521652A JP 2006528655 A5 JP2006528655 A5 JP 2006528655A5
Authority
JP
Japan
Prior art keywords
group
compound
formula
preparation
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006521652A
Other languages
English (en)
Japanese (ja)
Other versions
JP4820965B2 (ja
JP2006528655A (ja
Filing date
Publication date
Priority claimed from GB0317393A external-priority patent/GB0317393D0/en
Priority claimed from GB0406760A external-priority patent/GB0406760D0/en
Application filed filed Critical
Priority claimed from PCT/GB2004/003206 external-priority patent/WO2005012246A1/en
Publication of JP2006528655A publication Critical patent/JP2006528655A/ja
Publication of JP2006528655A5 publication Critical patent/JP2006528655A5/ja
Application granted granted Critical
Publication of JP4820965B2 publication Critical patent/JP4820965B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006521652A 2003-07-25 2004-07-23 スタチン、特にアトルバスタチンの調製において有用な方法および中間体化合物 Expired - Fee Related JP4820965B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0317393.7 2003-07-25
GB0317393A GB0317393D0 (en) 2003-07-25 2003-07-25 Process and compounds
GB0406760A GB0406760D0 (en) 2004-03-26 2004-03-26 Process and compounds
GB0406760.9 2004-03-26
PCT/GB2004/003206 WO2005012246A1 (en) 2003-07-25 2004-07-23 Process and intermediate compounds useful in the preparation of statins, particularly atorvastatin

Publications (3)

Publication Number Publication Date
JP2006528655A JP2006528655A (ja) 2006-12-21
JP2006528655A5 true JP2006528655A5 (https=) 2011-04-14
JP4820965B2 JP4820965B2 (ja) 2011-11-24

Family

ID=34117641

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006521652A Expired - Fee Related JP4820965B2 (ja) 2003-07-25 2004-07-23 スタチン、特にアトルバスタチンの調製において有用な方法および中間体化合物

Country Status (11)

Country Link
US (2) US7414141B2 (https=)
EP (2) EP1648866A1 (https=)
JP (1) JP4820965B2 (https=)
KR (1) KR101113163B1 (https=)
AU (1) AU2004261468B2 (https=)
BR (1) BRPI0412786A (https=)
CA (1) CA2530163C (https=)
HR (1) HRP20051020A2 (https=)
IL (1) IL173012A (https=)
NO (1) NO335650B1 (https=)
WO (1) WO2005012246A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1671947A1 (en) * 2004-12-20 2006-06-21 Ratiopharm GmbH Process for preparing pyrrole derivatives and intermediates
DE102005022284A1 (de) * 2005-05-13 2006-11-23 Ratiopharm Gmbh Verfahren zur Herstellung von Statinen
WO2009019561A2 (en) * 2007-08-03 2009-02-12 Pfizer Products Inc. Process for preparing chiral compounds
AU2013202895B2 (en) * 2009-03-10 2014-09-18 Redx Pharma Plc Rosuvastatin and atorvastatin derivatives
GB0904102D0 (en) * 2009-03-10 2009-04-22 Bradford Pharma Ltd Use of atorvastatin lactols as medicaments
GB0904104D0 (en) * 2009-03-10 2009-04-22 Bradford Pharma Ltd Atorvastatin and rosuvastatin derivatives
GB0904100D0 (en) * 2009-03-10 2009-04-22 Bradford Pharma Ltd Use of rosuvastatin lactols as medicaments

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4681893A (en) * 1986-05-30 1987-07-21 Warner-Lambert Company Trans-6-[2-(3- or 4-carboxamido-substituted pyrrol-1-yl)alkyl]-4-hydroxypyran-2-one inhibitors of cholesterol synthesis
US5003080A (en) 1988-02-22 1991-03-26 Warner-Lambert Company Process for trans-6-(2-(substituted-pyrrol-1-yl)alkyl)pryan-2-one inhibitors of cholesterol synthesis
FI94339C (fi) 1989-07-21 1995-08-25 Warner Lambert Co Menetelmä farmaseuttisesti käyttökelpoisen /R-(R*,R*)/-2-(4-fluorifenyyli)- , -dihydroksi-5-(1-metyylietyyli)-3-fenyyli-4-/(fenyyliamino)karbonyyli/-1H-pyrroli-1-heptaanihapon ja sen farmaseuttisesti hyväksyttävien suolojen valmistamiseksi
US5103024A (en) 1990-10-17 1992-04-07 Warner-Lambert Company Process for the synthesis of (4r-cis)-1,1-dimethylethyl 6-cyanomethyl-2,2-dimethyl-1,3-dioxane-4-acetate
US5298627A (en) * 1993-03-03 1994-03-29 Warner-Lambert Company Process for trans-6-[2-(substituted-pyrrol-1-yl)alkyl]pyran-2-one inhibitors of cholesterol synthesis
US5385929A (en) * 1994-05-04 1995-01-31 Warner-Lambert Company [(Hydroxyphenylamino) carbonyl] pyrroles
US5795749A (en) 1995-04-05 1998-08-18 The Scripps Research Institution Use of 2-deoxyribose-5-phosphate aldolase to prepare 2-deoxyfucose, analogues and derivatives
DE10131522A1 (de) * 2001-07-02 2003-01-16 Creavis Tech & Innovation Gmbh Verfahren zur Herstellung gesättigter Alkohole, Ketone, Aldehyde und Carbonsäuren
HRPK20040255B3 (en) * 2001-08-16 2006-02-28 Teva Pharmaceutical Industries Ltd. Processes for preparing calcium salt forms of statins
US7078430B2 (en) 2002-07-08 2006-07-18 Ranbaxy Laboratories Limited HMG CoA-reductase inhibitors
AU2003263031A1 (en) * 2002-09-20 2004-04-08 Diversa Corporation Chemoenzymatic methods for the synthesis of statins and stain intermediates
JP2006523670A (ja) 2003-04-14 2006-10-19 ワーナー−ランバート カンパニー リミティド ライアビリティー カンパニー 5−(4−フルオロフェニル)−1−[2−((2r,4r)−4−ヒドロキシ−6−オキソ−テトラヒドロ−ピラン−2−イル)エチル]−2−イソプロピル−4−フェニル−1h−ピロール−3−カルボン酸フェニルアミドの調製方法
PL1620423T3 (pl) * 2003-05-02 2008-07-31 Dsm Sinochem Pharm Nl Bv Sposób wytwarzania (4-hydroksy-6-okso-tetrahydropiran-2-ylo) acetonitrylu i jego pochodnych

Similar Documents

Publication Publication Date Title
TWI419867B (zh) 用於製備整合酶抑制劑之方法及中間體
JP6396462B2 (ja) フラン−2,5−ジメタノールおよび(テトラヒドロフラン−2,5−ジイル)ジメタノールのモノおよびジアルキルエーテルならびにその両親媒性誘導体
JP6633539B2 (ja) 2−(2,4−ジフルオロフェニル)−1,1−ジフルオロ−1−(5−置換−ピリジン−2−イル)−3−(1h−テトラゾール−1−イル)プロパン−2−オールおよびその調製工程
JP5579178B2 (ja) 2(s),4(s),5(s),7(s)−2,7−ジアルキル−4−ヒドロキシ−5−アミノ−8−アリール−オクタノイルアミドへの合成経路
US8614335B2 (en) Process and intermediates useful in the preparation of statins, particularly atorvastatin
JP3173602B2 (ja) エンイン誘導体の新規製造中間体及びその製造法
JP2006528655A5 (https=)
WO2008090046A1 (en) Alternate process for preparing 3,5-di-omicron-acyl-2-fluoro-2-c-methyl-d-ribono-gamma-lactone
WO2009084827A2 (en) Synthetic intermediates, process for preparing pyrrolylheptanoic acid derivatives therefrom
Geoffrey et al. Inhibitors of leukotriene B4. Synthesis and sar of new ß-enaminoester open-chain analogues of zeneca ZD2138
CA2608232A1 (en) Process for the production of statins
TWI781128B (zh) 製備殺蟲劑化合物的方法
RU2186771C2 (ru) Способ получения соединений 5-(алкоксиметил)-2,3-пиридиндикарбоксамида, промежуточные соединения
JPH09504548A (ja) N−[4−[(置換フェニル)アルキルチエニル]−及びn−4−[(置換フェニル)アルキルフリル]−ブト−3−イン−2−イル]−n−ヒドロキシ尿素化合物の製造方法
EP3562808B1 (en) Processes for the preparation of pesticidal compounds
EP0713865A1 (fr) Dérivés d'acide 2-aminobenzènesulfonique et de chlorure de 2-aminobenzènesulfonyle, leur préparation et leur utilisation comme intermédiaires de synthèse
JP4788049B2 (ja) ジカルボン酸ジエステル誘導体およびその製造方法
KR101142283B1 (ko) 2-아미노티아졸 카르복사미드 유도체의 신규한 제조방법
CN102020616B (zh) 一种2-(3-氧代吗啉基)乙腈的制备方法
EP4323333A1 (en) A process for preparation of substituted enamine compounds
WO2024126771A1 (en) Process for preparing (z)-3-(2-(5-bromo-1h-indol-3-yl)-2-cyanovinyl)-4-methoxybenzonitrile
JP2024518272A (ja) ハロシクロプロパン化プロセス
KR20090111994A (ko) 아트로바스타틴의 중간체로서 광학활성[6-2-(아미노에틸)-(4r,6r)-2,2-디메틸-[1,3]디옥산-4-일]아세트산 유도체의 제조방법
CN102712608A (zh) 环己烷衍生物的制造方法
JP2008524180A (ja) スタチンの調製に有用な製造方法及び中間体化合物